7DG
Based on 1 Customer Validation
7DG (7-Desacetoxy-6,7-dehydrogedunin) is a PKR inhibitor, P2X7 purinergic receptor inhibitor, and skin-lightening agent. 7DG binds outside the ATP-catalytic domain of PKR, blocks the kinase activity-independent protein-protein interactions of PKR, inhibits the phosphorylation and activity of PKR, disrupts ASC assembly and caspase-1 activation, and suppresses the activation of the NLRP1 inflammasome. 7DG inhibits pyroptosis, suppresses the ATP-P2X7 signaling pathway, and abolishes ATP-induced increases in the expression levels of MITF, tyrosinase, PMEL/gp100, and melanin content. 7DG exerts skin-lightening effects in cultured skin in vitro. 7DG can be used in research related to chronic obstructive pulmonary disease, gout, type 2 diabetes, Alzheimer's disease, and hyperpigmentary skin disorders.
For research use only. We do not sell to patients.
- Purity : 98%
- CAS No.: 26927-01-5
- Formula: C26H30O5
- Molecular Weight:422.51
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
Description
IC50 & Target
protein kinase R (PKR)[1]
In Vitro
7DG (0.001-10 μM; administered within up to 1 h after LT exposure) reversibly protects J774 macrophages from lethal toxin (LT)-induced pyroptotic cell death, with an IC50 of 5 μM, and remains active when added within 1 hour after LT exposure[1].
7DG (10 μM, 2 h) inhibits LT-induced caspase-1 activation in J774 macrophages by targeting upstream steps of caspase-1 activation, without directly inhibiting the enzymatic activity of caspase-1[1].
7DG (20 μM; 2 h) inhibits LPS (HY-D1056)-induced IκBβ degradation in J774 macrophages, and suppresses NLRP3 inflammasome-mediated caspase-1 activation in J774 macrophages treated with LPS + nigericin[1].
7DG (1 h) inhibits the assembly of NLRP1 and NLRP3 inflammasomes in immortalized mouse macrophages with constitutive NLRP3 expression by targeting the kinase-independent function of PKR[1].
7DG directly targets PKR in macrophages, inhibits PKR phosphorylation, and protects macrophages from LT-induced NLRP1 inflammasome-mediated pyroptosis[2].
7DG (5.6-50 μM; 30 min) inhibits P2X7 activity in HOS-P2X7 cells[3].
Incubation with 10 μM 7DG for 4 days (within the concentration range of 0.1-10 μM over 4 days) significantly reduces the viability of PHEM cells[3].
7DG (0.5-2 μM; 1 h pre-incubation, followed by 3 days of co-treatment with 100 μM ATP) potently inhibits ATP (HY-B2176)-induced P2X7 activity in PHEMs[3].
7DG (0.5-2 μM; 1 h pre-incubation followed by 72 h co-treatment with 100 μM ATP) inhibits ATP-induced melanogenesis in PHEMs by reducing the expression of melanogenesis-related proteins, tyrosinase activity, and melanin content[3].
7DG (0.5-2 μM; 4-72 h) reduces melanogenesis in PHEMs without ATP stimulation[3].
7DG (2 μM, daily for 9 consecutive days, with UVB irradiation supplemented on days 5 to 7) inhibits UVB-induced pigmentation in organ-cultured human skin after 9 days of treatment[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:J774A.1 BALB/c murine macrophages (J774)
-
Concentration:0.001, 0.01, 0.1, 1, 10 μM
-
Incubation Time:up to 1 h after LT exposure
-
Result:Completely protected J774 macrophages from LT-induced death at 10 μM, with an IC50 of 5 μM.
Retained protective activity when added up to 1 hour after LT exposure, but not at later time points.
Lost all protective activity after washout, indicating it acts as a reversible inhibitor.
-
Cell Line:J774 macrophages
-
Concentration:20 μM
-
Incubation Time:2 h (pre-treatment); 30-40 min (LPS exposure)
-
Result:Prevented LPS-induced IκBβ degradation in J774 macrophages, similar to the proteasome inhibitor Epoxo, which blocks IκBβ degradation.
Chemical Information
-
CAS No. 26927-01-5
-
Appearance Solid
-
Molecular Weight 422.51
-
Formula C26H30O5
-
Color White to off-white
-
SMILES
O=C1O[C@@H](C2=COC=C2)[C@]3(C)CC[C@@]4([H])[C@](C=C[C@@]5([H])C(C)(C)C(C=C[C@@]54C)=O)(C)[C@@]36[C@@H]1O6
-
Synonyms
7-Desacetoxy-6,7-dehydrogedunin
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
-
Pyroptosis Solutions
Pyroptosis is a lytic inflammatory cell-death pathway executed by gasdermin pores, most classically through inflammasome-mediated activation of caspase-1, cleavage of gasdermin D, membrane pore formation, LDH release, and secretion of IL-1β and IL-18. The canonical pathway is commonly modeled by priming cells with an inflammatory signal such as LPS to induce pro-IL-1β and inflammasome components, followed by an activation signal such as ATP or nigericin to activate NLRP3, ASC speck formation, caspase-1 cleavage, GSDMD cleavage, cytokine release, and pyroptotic membrane rupture. The non-canonical pathway is triggered when cytosolic LPS activates mouse caspase-11 or human caspase-4/5, leading to GSDMD cleavage and pyroptosis, and this can secondarily activate NLRP3-dependent IL-1β release. Pyroptosis is linked to inflammatory injury, infection, cancer, liver disease, ocular disease, placental inflammation, and other disease phenotypes, but unresolved questions include which gasdermin fam
-
Alzheimer’s Disease Modeling
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive functions and loss of specific types of neurons and synapses. Alzheimer's symptoms can be simulated in mice by injecting drugs (such as Aβ) or genetically modified.
Purity & Documentation
-
Data Sheet (281 KB)
-
SDS (392 KB)
- English - EN (392 KB)
- Français - FR (392 KB)
- Deutsch - DE (392 KB)
- Norwegian - NO (392 KB)
- Español - ES (392 KB)
- Swedish - SV (392 KB)
- Italian - IT (392 KB)
- Korean - KR (392 KB)
- Portuguese - PT (392 KB)
-
Handling Instructions (2659 KB)
References
[1]. Hett EC, et al. Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis. Nat Chem Biol. 2013;9(6):398-405. [Content Brief]
[2]. Chukwurah E, et al. A tale of two proteins: PACT and PKR and their roles in inflammation. FEBS J. 2021;288(22):6365-6391. [Content Brief]
[3]. Park S, et al. 7-desacetoxy-6,7-dehydrogedunin discovered by high-throughput screening system suppresses melanogenesis through ATP-P2X7 signaling inhibition. J Dermatol Sci. 2022;108(3):157-166. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)